David A. Siegel Acrivon Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

  • $47 Billion
  • Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 136,500 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,500
Previous 32,600 318.71%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
BUY
N/A
103,900 Added 318.71%
136,500 $0
Q2 2025

Aug 14, 2025
BUY
N/A
32,600 New
32,600 $0

Others Institutions Holding ACRV

# of Institutions
47
Shares Held
18.2M
Call Options Held
0
Put Options Held
0
View Full List

About Acrivon Therapeutics, Inc.

ACRV Quotes by TradingView
  • Ticker ACRV
More about ACRV
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email